MeiraGTx Holdings (MGTX) Gains from Sales and Divestitures (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Gains from Sales and Divestitures of $1.2 million for Q4 2025, up 21.95% on a YoY basis from $1.0 million in Q4 2024, and little changed quarter-over-quarter from $1.2 million in Q3 2025.
MeiraGTx Holdings (MGTX) Gains from Sales and Divestitures (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Gains from Sales and Divestitures for 8 years, with the latest figure at $1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 21.95% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (up 21.95% YoY), and the FY2025 full-year result was $1.2 million, up 21.95% from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $1.2 million, roughly flat from $1.2 million in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.2 million in Q3 2025, with the low at $272500.0 in Q1 2022.
- Historically, Gains from Sales and Divestitures has averaged $737343.8 across 4 years, with a median of $704375.0 in 2023.
- Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures surged 103.22% — and 2025, when it advanced 9.18%.
- MeiraGTx Holdings' Gains from Sales and Divestitures stood at $397500.0 in 2022, then jumped by 55.66% to $618750.0 in 2023, then surged by 62.02% to $1.0 million in 2024, then rose by 21.95% to $1.2 million in 2025.
- The last three Gains from Sales and Divestitures figures came in at $1.2 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.22 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 862,500.00 |
| Mar 31, 2025 | 862,500.00 |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 942,500.00 |
| Jun 30, 2024 | 942,500.00 |
| Mar 31, 2024 | 790,000.00 |
| Mar 31, 2024 | 790,000.00 |
| Dec 31, 2023 | 618,750.00 |
| Dec 31, 2023 | 618,750.00 |
| Sep 30, 2023 | 618,750.00 |
| Sep 30, 2023 | 618,750.00 |